|
演講者 Abdellah Allali-Hassani, Ph.D., Team Leader, Enzymatic Assays, Structural Genomics Consortium, University of Toronto Abraham Brass, M.D., Ph.D., Assistant Professor, Department of Microbiology and Physiology Systems, University of Massachusetts Medical School Adrian L. Smith, Ph.D., Scientist, Amgen (tentative) Andrei Gartel, Ph.D., Associate Professor, Medicine, University of Illinois Andrew Alt, Ph.D., Senior Research Investigator, Lead Discovery, Bristol-Myers Squibb Andrew C. Adams, Ph.D., Post-Doctoral Research Fellow, Diabetes Research, Lilly Research Laboratories Andrew Ferguson, Ph.D., Principal Scientist, DECS Structural Chemistry, AstraZeneca Pharmaceuticals Andrew Tobin, Ph.D., Professor of Cell Biology, Cell Physiology and Pharmacology, MRC Toxicology Unit, University of Leicester Andy Whitlock, Ph.D., Director, Pre-Clinical Development, Ora, Inc. Annette Gilchrist, Ph.D., Assistant Professor, Pharmaceutical Sciences, Midwestern University Arthur Christopoulos, Ph.D., Professor, Department of Pharmacology, Monash University Attila Seyhan, Ph.D., Senior Biomarker Discovery and Development Leader, formerly at Translational Immunology, Biotherapeutics Clinical R&D, Pfizer, Inc. Ayesha B. Alvero, M.D., M.S., Associate Research Scientist, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine Barden Chan, Ph.D., Instructor, Medicine, Beth Israel Deaconess Medical Center Ben Nicholson, Ph.D., Director, Biology, Progenra Bernard B. Allan, Ph.D., Scientist, Department of Molecular Biology, Genentech, Inc. Blaine N. Armbruster, Ph.D., Senior Manager, Discovery & Development Solutions, EMD Millipore Corporation Brad Fell, Senior Research Investigator, Medicinal Chemistry, Array BioPharma Brian Lannutti, Ph.D., Associate Director, Cancer Research, Gilead Sciences, Inc. Bridget K. Wagner, Ph.D., Director of Pancreatic Cell Biology, Chemical Biology Program, The Broad Institute of MIT and Harvard Bryan Laffitte, Ph.D., Associate Director, Genomics Institute of the Novartis Research Foundation Carrie K. Jones, Ph.D., Assistant Professor, Pharmacology, Vanderbilt University (invited) Charles E. Wenner, Ph.D., Professor, Member, Molecular and Cellular Biology, Roswell Park Cancer Institute Christian Felder, Ph.D., Research Scientist, Neuroscience, Eli Lilly & Co. Christoph M. Dehnhardt, Ph.D., Senior Principle Scientist,, Pfizer Global R&D WWMC Christophe Echeverri, Ph.D., CEO & CSO, Cenix BioScience Christopher Barker, M.D., Assistant Attending Physician, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center Christopher Koth, Ph.D., Scientist, Structural Biology, Genentech Claire Steppan, Ph.D., Associate Research Fellow, Diabetes, Pfizer Claudio Chuaqui, Ph.D., Principle Scientist II, Astrazeneca R&D Dafydd Owen, Ph.D., Associate Research Fellow, Pfizer, Inc. Dana Johnson, Ph.D., Senior Scientific Director, Drug Discovery, Janssen Pharmaceuticals, Johnson & Johnson Daniel Finley, Ph.D., Professor, Cell Biology, Harvard Medical School Dario Doller, Ph.D., Director, Discovery Chemistry & DMPK, Lundbeck Research USA David J. Matthews, Ph.D., Vice President, Drug Discovery & Exploratory Development, Pathway Therapeutics, Inc. David Proia, Ph.D., Senior Scientist, Synta Pharmaceutical David Root, Ph.D., Director, RNAi Platform and Project Leader, The RNAi Consortium, The Broad Institute of MIT and Harvard David Shum, Ph.D., Assay Development Specialist, HTS Core Facility, Memorial Sloan Kettering Cancer Center David W. Moskowitz, M.D., M.A., FACP, CEO, GenoMed, Inc. Denis Drygin, Ph.D., Vice President, Biology, Cylene Pharma Domagoj Vucic, Ph.D., Senior Scientist, Early Discovery Biochemistry, Genentech, Inc. Donald Durden, M.D., Ph.D.,Vice Chair for Research, Department of Pediatrics, University of California San Diego; Associate Director, Pediatric Oncology, Moores UCSD Cancer Center Drew Adams, Ph.D., Research Scientist, Chemical Biology Program, The Broad Institute Edward Holson, Ph.D., Director, Medicinal Chemistry, Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard Elizabeth Maher, M.D., Ph.D., Associate Professor, Theodore H. Strauss Professorship in Neuro-Oncology, Southwestern Medical Center Ety Klinger, Ph.D., Vice President, Research & Development, Proteologics Eugen Buehler, Ph.D., Group Leader, Informatics, National Center for Advancing Translational Sciences, National Institutes of Health Fang Tian, Ph.D., Scientist, Cell Biology, ATCC Feng Cong, Ph.D., Scientist, Novartis Gabriel Baverel, Ph.D., Professor, CEO, CSO, Metabolomics, Metabolys, Inc. Ganesh Thakur, Ph.D., Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University Gary L. Johnson, Ph.D., Kenan Distinguished Professor and Chair, Department of Pharmacology, University of North Carolina School of Medicine Graeme Semple, Ph.D., Vice President, Discovery Chemistry, Arena Pharmaceuticals, Inc. Guillaume Duvey, Ph.D., Group Leader, In Vitro Pharma, Addex Hakim Djaballah, Ph.D., Director, HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center Hidde Ploegh, Ph.D., Member, Whitehead Institute for Biomedical Research, Professor of Biology, Massachusetts Institute of Technology Hong Xin, Ph.D., Scientist/Technologist, Lead Generation, Johnson & Johnson PRD Iqbal Sayeed, Ph.D., Assistant Professor, Emergency Medicine, Emory University Jacques Ermolieff, Ph.D., Senior Principal Scientist, External Research Solutions (ERS), Pfizer Worldwide Research and Development James A. Bibb, Ph.D., Associate Professor, Departments of Psychiatry, and Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center James Dykens, CEO, Eyecyte Therapeutics James E. Bradner, M.D., Assistant Professor, Department of Medicine, Harvard Medical School and Investigator, Department of Medical Oncology, Dana-Farber Cancer Institute James Gleason, Ph.D., Associate Professor, Department of Chemistry, McGill University James R. Brown, Ph.D., Computational Biology, Quantitative Sciences, R&D, GlaxoSmithKline Jan Hoflack, Ph.D., CSO, Drug Discovery, Oncodesign Biotechnology Jan Steyaert, Ph.D., Professor, Structural Biology Department, Vrije University of Brussels Jean-Francois Geschwind, M.D., Professor, Director, Interventional Radiology Division, Radiology & Radiological Sciences, Johns Hopkins University School of Medicine Jeffrey A. Robl, Ph.D., Executive Director, Metabolic Diseases R&D, Bristol-Myers Squibb Jian Jin, Ph.D., Associate Professor and Director, Medicinal Chemistry, Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill Ji-Hu Zhang, Ph.D., Senior Research Investigator, Center for Proteomic Chemistry, Lead Finding Platform, Novartis Institute for Biomedical Research, Inc. Jing Li, Ph.D., Director of Genomics Screening, Discovery and Pre-clinical Science, Merck Research Laboratories Joan Ballesteros, Ph.D., CEO, Vivia Allosterics SL Joel Gottesfeld, Ph.D., Professor, Department of Molecular Biology, The Scripps Institute John Corbin, Ph.D., Associate Director, Molecular Interactions and Biophysics, Preclinical Research, XOMA John Doedens, Ph.D., Scientist, formerly Amgen John Robinson, Ph.D., Senior Scientist, Medicinal Chemistry, Array Johnathan R. Whetstine, Ph.D., Assistant Professor, Medicine, Harvard Medical School; Massachusetts General Hospital Cancer Center Jose M. Silva, Ph.D., Assistant Professor, Pathology, Institute for Cancer Genetics, Irving Cancer Research Center, Columbia University Joseph Garlich, Ph.D., Stemica LLC Joseph Pero, Ph.D., Senior Research Chemist, Medicinal Chemistry, Merck Juergen Dohmen, Ph.D., Group Leader, Institute for Genetics, University of Cologne Justin Hall, Ph.D., Senior Scientist, Structural Biology and Biophysics, Pfizer Kapil Dhingra, M.D., Managing Member, KAPital Consulting LLC Kaylene Simpson, Ph.D., Head, Victorian Centre for Functional Genomics, Cancer Genetics, Peter MacCallum Cancer Centre, Australia Kenneth Foon, M.D.,Vice President, Disease State Lead, Medical Affairs, Celgene Kim McClure, Ph.D., Senior Principal Scientist, Pfizer Konrad T. Howitz, Ph.D., Director, Epigenetics, Reaction Biology Corporation Levi Blazer, Ph.D., Scientist, Molecular Screening, Cayman Chemical Liz Quinn, Ph.D., Marketing Director, LeadHunter Discovery Services, DiscoveRx Marc O'Reilly, Ph.D., Associate Director, Structural Biology, Astex Pharmaceuticals Marco Falasca, Ph.D., Professor in Molecular Pharmacology, Blizard Institute, Queen Mary University of London Maria Gaczynska, Ph.D., Associate Professor, Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio Marina Roell, Ph.D., Director, Molecular Interactions and Informatics, XOMA Mark Ashwell, Ph.D., Vice President, Chemistry, Arqule (tentative) Markus Schirle, Senior Investigator I, Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Inc. Matthew D. Petroski, Ph.D., Assistant Professor, Sanford-Burnham Medical Research Institute Michael Hanson, Ph.D., Director, Structural Biology, Receptos Michael McCabe, Ph.D., Investigator, Biology, Cancer Epigenetics Discovery Performance Unit, Oncology R&D, GlaxoSmithKline Pharmaceuticals Michael Ollmann, Ph.D., Principal Scientist, Discovery Technologies, Amgen, Inc. Michael P. Lisanti, M.D., Ph.D., Director and Chair, Stem Cell Biology and Regenerative Medicine Center; Landenberger Endowed Professor in Breast Cancer Research; Professor of Cancer Biology, Medical Oncology, and Biochemistry, Kimmel Cancer Center, Thomas Jefferson University Namjin Chung, Ph.D., Senior Research Investigator, Applied Genomics, Bristol-Myers Squibb Co. Neil Burford, Senior Research Investigator II, Lead Discovery & Profiling, Molecular Sciences and Candidate Optimization, Bristol-Myers Squibb Company Nikolaus S. Trede, M.D., Ph.D., Associate Professor of Pediatrics, Investigator, The Huntsman Cancer Institute, University of Utah Norma Kenyon, Ph.D., Professor of Surgery, Microbiology and Immunology and Biomedical Engineering; Executive Director of the Wallace H. Coulter Center for Translational Research; School of Medicine, University of Miami Or Gozani, M.D., Ph.D., Associate Professor, Department of Biology, Stanford University Patrick Trojer, Ph.D., Director, Biology, Constellation Pharmaceuticals Paul Andrews, Ph.D., Scientist, Amgen (tentative) Paul Bingham, Ph.D., Vice President, Research, Cornerstone Pharmaceuticals Paul Diehl, Ph.D., Director, Business Development, Cellecta, Inc. Peter Cornelius, Ph.D., Director of Metabolic Diseases, SystaMedic Inc. Peter Ordentlich, Ph.D., Executive Director, Translational Science & Founder, Syndax Pharmaceuticals Philip Fallon, Ph.D., Senior Medicinal Chemist, Domainex, Ltd. Pratul Agarwal, Ph.D., Staff Scientist at Oak Ridge National Laboratory Qin Yan, Ph.D., Assistant Professor, Pathology, Yale University School of Medicine Ralph Mazitschek, Ph.D., Assistant Professor, Center for Systems Biology, Chemical Biology Platform, Massachusetts General Hospital Raul Mostoslavsky, M.D., Ph.D., Assistant Professor, The Massachusetts General Hospital Cancer Center, Harvard Medical School Rebecca Taub, M.D., CEO, Madrigal Pharmaceuticals Robert Hills, Ph.D., Senior Scientist, Lead Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson Roberto Pili, M.D., Professor of Oncology and Chief of Genitourinary Section, Leader of the GU Program, Roswell Park Cancer Institute Roger Macklis, M.D., Professor of Medicine, Radiation Oncology, Cleveland Clinic Ron Dror, Ph.D., Senior Research Scientist, D. E. Shaw Research Roy Pollock, Ph.D., Director, Biological Sciences, Epizyme Ryan Kruger, Ph.D., Manager, Cancer Epigenetics Discovery Performance Unit, Oncology R&D, GlaxoSmithKline Pharmaceuticals Scott Biller, Ph.D., CSO, Cancer Metabolism, Agios Pharmaceuticals Scott Martin, Ph.D., Team Leader, RNAi Screening, NIH Chemical Genomics Center, NIH Center for Translational Therapeutics, National Institutes for Health Sebastian Nijman, Ph.D., Principal Investigator, Chemical Genomics, The Research Center for Molecular Medicine, Vienna, Austria Serena Silver, Ph.D., Principal Research Investigator, Sanofi Oncology Target Discovery Shirly Pinto, Ph.D., CVD - Atherosclerosis Team Lead, Merck Research Laboratories Simeon Ramsey, Ph.D., Senior Principal Scientist, Inflammation, Pfizer Sreenivas Gannavaram, Ph.D., Scientist, Division of Emerging and Transfusion Transmitted Diseases, OBRR/CBER/FDA Stefan W. Henning, Ph.D., M.Sc., Senior Project Manager, Development, 4SC AG Stefen Boehme, Ph.D., Director, Immunology, Axicin Pharmaceuticals Stephen J. Shuttleworth, Ph.D., FRSC CChem, CSO, Karus Therapeutics Ltd. Stephen Ward, Ph.D., Professor, Inflammatory Cell Biology; Head of Pharmacology, Department of Pharmacy & Pharmacology, University of Bath Thomas E. Salt, Ph.D., Professor, Department of Visual Neuroscience, University College of London Institute of Ophthalmology Timothy A. McKinsey, Ph.D., Associate Professor and Associate Division Head for Translational Research, Department of Medicine, Division of Cardiology, University of Colorado Denver Timothy Heffron, Ph.D., Scientist, Genentech Timothy Lovenberg, Ph.D., Senior Research Fellow, Neuroscience, J&J La Jolla Tso-Pang Yao, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University Uli Hacksell, Ph.D., CEO, Acadia Pharmaceuticals Vincent Aguirre, M.D., Ph.D., Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center Vincent Jacques, Ph.D., Senior Director, Pre-Clinical Development, Repligen Corporation Vincent Mascitti, Ph.D., Senior Director, Pfizer Global R&D Vladimir Kirkin, Ph.D., Senior Scientist, Merck-Serono; Research & Early Development, Oncology Platform, In Vivo Pharmacology, Merck KGaA W. Matthew Dickerson, Ph.D., Senior Scientist , Assay Development, BioScale, Inc. Wayne W. Hancock, M.D., Ph.D., Professor of Pathology and Chief of Transplant Immunology, Children's Hospital of Philadelphia and University of Pennsylvania Wen Jin Wu, Ph.D., Principal Investigator (PI), Division of Monoclonal Antibodies, Office of Biotechnology Products, Food and Drug Administration (FDA) William P. Clarke, Ph.D., Professor, Department of Pharmacology, University of Texas Health Science Center Yaya Liu, Associate Research Fellow, Neuroscience/Pain, Abbott Laboratories Yi Huang, M.D., Ph.D., Assistant Professor, University of Pittsburgh Cancer Institute Zheng-Gang Liu, Ph.D., Senior Investigator, Cell and Cancer Biology Branch, Center for Cancer Research, NCI, NIH |
